Anti–TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis.

MLA

Straumann, Alex, et al. “Anti–TNF-α (Infliximab) Therapy for Severe Adult Eosinophilic Esophagitis.” Journal of Allergy & Clinical Immunology, vol. 122, no. 2, Aug. 2008, pp. 425–27. EBSCOhost, https://doi.org/10.1016/j.jaci.2008.06.012.

APA

Straumann, A., Bussmann, C., Conus, S., Beglinger, C., & Simon, H.-U. (2008). Anti–TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis. Journal of Allergy & Clinical Immunology, 122(2), 425–427. https://doi.org/10.1016/j.jaci.2008.06.012

Chicago

Straumann, Alex, Christian Bussmann, Sébastien Conus, Christoph Beglinger, and Hans-Uwe Simon. 2008. “Anti–TNF-α (Infliximab) Therapy for Severe Adult Eosinophilic Esophagitis.” Journal of Allergy & Clinical Immunology 122 (2): 425–27. doi:10.1016/j.jaci.2008.06.012.